Die folgenden Begriffe wurden einbezogen:
Kanzerogenität, Karzinogenität, carcinogenicity, 発がん性
-
2003,
McLean JR, Thansandote A, McNamee JP, Tryphonas L, Lecuyer D, Gajda G
Bioelectromagnetics 24 (2): 75-81
-
2002,
Harris PA, Lamb J, Heaton B, Wheatley DN
Cancer Cell Int 2: 3
-
2002,
Fedrowitz M, Westermann J, Loscher W
Cancer Res 62 (5): 1356-1363
-
2001,
Frumkin H, Jacobson A, Gansler T, Thun MJ
CA Cancer J Clin 51 (2): 137-141
-
2001,
Krewski D, Byus CV, Glickman BW, Lotz WG, Mandeville R, McBride ML, Prato FS, Weaver DF
J Toxicol Environ Health B Crit Rev 4 (1): 1-143
-
Acta Oncol 39 (8): 927-930
-
2000,
Jin M, Blank M, Goodman R
J Cell Biochem 78 (3): 371-379
-
Radiat Res 153 (5) Pt 2: 613-616
-
2000,
McCann J, Kavet R, Rafferty CN
Environ Health Perspect 108: 79-100
-
2000,
Maruvada PS, Harvey SM, Jutras P, Goulet D, Mandeville R
Bioelectromagnetics 21 (6): 432-438
-
1999,
Ahlbom A, Feychting M
Ann N Y Acad Sci 895: 27-33
-
1999,
Gauger JR, Johnson TR, Stangel JE, Patterson RC, Williams DA, Harder JB, McCormick DL
Bioelectromagnetics 20 (1): 13-23
-
Toxicol Pathol 27 (3): 286
-
1998,
Imaida K, Taki M, Watanabe S, Kamimura Y, Ito T, Yamaguchi T, Ito N, Shirai T
Jpn J Cancer Res 89 (10): 995-1002
-
1997,
Wireless Technology Research, L.L.C.
Hum Ecol Risk Assess 3 (1): 51-58
-
1997,
Juutilainen J, Lang S
Mutation Research - Reviews in Mutation Research 387 (3): 165-171
-
1997,
Mandeville R, Franco E, Sidrac-Ghali S, Paris-Nadon L, Rocheleau N, Mercier G, Desy M, Gaboury L
FASEB J 11 (13): 1127-1136
-
Bioelectromagnetics 18 (2): 156-165
-
1997,
Yasui M, Kikuchi T, Ogawa M, Otaka Y, Tsuchitani M, Iwata H
Bioelectromagnetics 18 (8): 531-540
-
1996,
Coste D, Moutet JP, Bernard JL
Rev Epidemiol Sante Publique 44 (1): 80-92
-
1996,
Guenel P, Nicolau J, Imbernon E, Chevalier A, Goldberg M
Am J Epidemiol 144 (12): 1107-1121
-
Public Health Rep 111 (3): 204-217
-
Bioelectromagnetics 17 (5): 339-357
-
1995,
Shimizu H, Suzuki Y, Okonogi H
Nihon Eiseigaku Zasshi 50 (5): 919-931
-
Cancer Detect Prev 19 (3): 244-249